About us
Discover the essence of our ethos
Mission
To increase access to radiopharmaceutical therapeutics and diagnostics through:
- High quality, reliable manufacturing for our partner companies
- Registration and commercialization of radiopharmaceutical products.
Vision
We will significantly improve the options for cancer patients through radiopharmaceuticals
Values
We act with urgency
Patients and customers are waiting – their lives depend on us (and many others). Acting with urgency means we need to be focused on what matters and get the job done with only the highest quality standards.
We are authentic
Getting the best out of each other requires us to speak up, transparently and honestly. We’re all working toward the same goals.
We are humble
We all have a lot to learn, and by learning we improve what we do every day. We can only do this by being curious to know more, and to respect others and their expertise.
Our team
Management
Dipesh Patel
GENERAL COUNSEL
Dipesh Patel is responsible for legal, compliance, litigation, and transactional functions.
Dipesh has served as our General Counsel since May 2023. Dipesh supports Evergreen’s commercial, compliance, and regulatory operations to align with Evergreen’s legal strategies to ensure solutions to assist Evergreen in achieving its business and development objectives. Prior to joining Evergreen, Dipesh served as general counsel for Rising Pharmaceuticals. Mr. Patel started his legal career practicing restructuring and insolvency law. Dipesh holds a Bachelor of Arts from Seton Hall University and a Juris Doctor degree from Rutgers University.
Tom Reiner, PhD
CHIEF SCIENTIFIC OFFICER
Tom Reiner, PhD serves as the Chief Scientific Officer at Evergreen Theragnostics. At Evergreen, Tom oversees the preclinical and clinical development of novel radiotherapeutic agents. Together with his team, he seeks to conceive and develop novel radiolabeled vectors, in order to visualize and treat some of the most devastating malignancies.
Prior to Evergreen, Tom was the Executive Director and Radioligand Therapy Lead, at the Novartis Institutes for Biomedical Research (NIBR). Tom also served as Head, Radioligand Therapy Drug Discovery for Advanced Accelerator Applications (AAA), a Novartis Company. He was also a member of the AAA Executive Leadership Team, and a member of the Sloan Kettering Institute Chemical Biology Program.
Tom had also served as an Associate Member and Laboratory Head at Memorial Sloan Kettering Cancer Center (from 2012 to 2021). He held affiliations as an Associate Professor at Gerstner Sloan Kettering Graduate School of Biomedical Sciences and as Associate Professor at Weill Cornell Medical College.Tom received his Ph.D. from the Technical University of Munich in Germany.
Alison Tillbrook
VP of Human Resources
Alison serves as the VP, Head of Human Resources for Evergreen since joining in November of 2022. Her experience in HR began in recruiting in ecommerce and consulting leading to partnership and leadership roles in Financial Services and Asset Management in a large corporate environment. After leaving corporate asset management she moved into a startup consulting company firm as Senior Director, building out the people and culture of the company alongside the founders and contributing to the successful acquisition of the firm. From there she stayed with the challenges of running HR in small company start up environments, both at a private insurance company and a Healthcare service company before joining Evergreen.
Alison has her BA in Political Science and her Senior HR Professional (SPHR) accreditation with the Human Resources Certification Institute. In her spare time, she likes to rescue and feed all animals, coach CrossFit, and spend time with her family.